An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe".
Jit, Mark;
Mangen, Marie-Josée J;
Melliez, Hugues;
Yazdanpanah, Yazdan;
Bilcke, Joke;
Salo, Heini;
Edmunds, W John;
Beutels, Philippe;
(2010)
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe".
Vaccine, 28 (47).
pp. 7457-7459.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2010.08.060
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices.
